0001144204-16-080445.txt : 20160210
0001144204-16-080445.hdr.sgml : 20160210
20160210174459
ACCESSION NUMBER: 0001144204-16-080445
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160209
FILED AS OF DATE: 20160210
DATE AS OF CHANGE: 20160210
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Tonix Pharmaceuticals Holding Corp.
CENTRAL INDEX KEY: 0001430306
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 261434750
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 509 MADISON AVE. - SUITE 306
CITY: NEW YORK
STATE: NY
ZIP: 10022
BUSINESS PHONE: 1-800-849-7894
MAIL ADDRESS:
STREET 1: 509 MADISON AVE. - SUITE 306
CITY: NEW YORK
STATE: NY
ZIP: 10022
FORMER COMPANY:
FORMER CONFORMED NAME: TAMANDARE EXPLORATIONS INC.
DATE OF NAME CHANGE: 20080320
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LANDRY DONALD W
CENTRAL INDEX KEY: 0001563616
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36019
FILM NUMBER: 161406923
MAIL ADDRESS:
STREET 1: C/O TONIX PHARMACEUTICALS HOLDING CORP
STREET 2: 509 MADISON AVE., STE 306
CITY: NEW YORK
STATE: NY
ZIP: 10022
4
1
v431271_4.xml
OWNERSHIP DOCUMENT
X0306
4
2016-02-09
0
0001430306
Tonix Pharmaceuticals Holding Corp.
TNXP
0001563616
LANDRY DONALD W
C/O TONIX PHARMACEUTICALS HOLDING CORP
509 MADISON AVE., STE 306
NEW YORK
NY
10022
1
0
0
0
Restricted Stock Unit
2016-02-09
4
A
0
7500
0.00
A
Common Stock
7500
7500
D
Each restricted stock unit represents the right to receive, at settlement, one share of common stock.
These restricted stock units are scheduled to vest 100% on February 9, 2017.
The restricted stock units were granted pursuant to the Issuer's 2014 Stock Incentive Plan.
/s/Jessica Morris, Attorney-in-Fact
2016-02-10